iSpecimen Inc reports results for the quarter ended in September - Earnings Summary

iSpecimen

02/11/2023 13:32

* iSpecimen Inc  ISPC.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of -35 cents.  The lone analyst forecast for the quarter was
for a loss of 35 cents per share. 
    * Revenue rose 7.5% to $2.78 million from a year ago;
analysts
expected $2.24 million. 
    * iSpecimen Inc's reported EPS for the quarter was a loss
of 23
cents​.
    * The company reported a quarterly loss of $2.11 million.
    * iSpecimen Inc shares had risen by 5.9% this quarter and
lost 52.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for iSpecimen Inc is
$5.00 
This summary was machine generated from LSEG data November 2 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.35          -0.23          Beat
 Jun. 30 2023      -0.30          -0.39          Missed
 Mar. 31 2023      -0.32          -0.27          Beat
 Dec. 31 2022      -0.37          -0.24          Beat